cilostazol has been researched along with Angina Pectoris in 3 studies
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol is an effective therapy for patients with VSA uncontrolled by conventional amlodipine therapy, and has no serious side effects." | 2.79 | A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. ( Hong, YJ; Jeong, YH; Kim, JH; Kim, JS; Kim, MH; Lee, CW; Lee, JH; Lee, JY; Nam, CW; Park, Y; Shin, ES; Shin, HK; Tahk, SJ; Yoo, SY, 2014) |
| "Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic adenosine monophosphate (cAMP) contents." | 1.39 | Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study. ( Chun, KJ; Kim, J; Kim, JH; Kim, JS; Lee, JH; Park, YH; Shin, ES; Song, SG; Yoo, SY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, ES | 2 |
| Lee, JH | 2 |
| Yoo, SY | 2 |
| Park, Y | 1 |
| Hong, YJ | 1 |
| Kim, MH | 1 |
| Lee, JY | 1 |
| Nam, CW | 1 |
| Tahk, SJ | 1 |
| Kim, JS | 2 |
| Jeong, YH | 1 |
| Lee, CW | 1 |
| Shin, HK | 1 |
| Kim, JH | 2 |
| Song, SG | 1 |
| Park, YH | 1 |
| Kim, J | 1 |
| Chun, KJ | 1 |
| Watanabe, K | 1 |
| Ikeda, S | 1 |
| Komatsu, J | 1 |
| Inaba, S | 1 |
| Suzuki, J | 1 |
| Sueda, S | 1 |
| Funada, J | 1 |
| Kitakaze, M | 1 |
| Sekiya, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of PletaalÒ(Cilostazol) in Subjects With Vasospastic Angina (STELLA)[NCT01444885] | Phase 2 | 50 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for cilostazol and Angina Pectoris
| Article | Year |
|---|---|
A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina.
Topics: Adult; Angina Pectoris; Chest Pain; Cilostazol; Coronary Vasospasm; Dose-Response Relationship, Drug | 2014 |
Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris.
Topics: Angina Pectoris; Cilostazol; Coronary Circulation; Endothelium, Vascular; Female; Hemodynamics; Huma | 2003 |
1 other study available for cilostazol and Angina Pectoris
| Article | Year |
|---|---|
Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.
Topics: Adult; Aged; Angina Pectoris; Cilostazol; Coronary Vasospasm; Female; Humans; Male; Middle Aged; Pho | 2013 |